Kadcyla Approved to Treat Early-Stage HER2+ Breast Cancer

Moderators
Moderators Member Posts: 25,912
edited May 2019 in HER2+ (Positive) Breast Cancer

Kadcyla Approved to Treat Early-Stage HER2-Positive Breast Cancer
May 7, 2019
On May 3, 2019, the FDA approved Kadcyla to treat early-stage HER2-positive breast cancer after surgery if there were cancer cells found during surgery after neoadjuvant chemotherapy with a taxane and Herceptin. Read more...

· Share on FacebookShare on Twitter

Comments

  • Melissa387
    Melissa387 Member Posts: 5
    edited May 2019

    I just had my first maintenance treatment of Herceptin/Perjeta. I advocated for the Kadcyla 2 weeks ago. My MO informed be today he thought we should go with the Kadcyla for 16 treatments in place of the Herceptin/perjeta. I am unsure of what to do. Although the Katherine study shows Kadcyla had better results. After 3 years 88% were disease free vs 77% for Herceptin. Im scared bc I know herceptin has been around for years. I did not have a complete response to neoadjuvant therapy

    · Share on FacebookShare on Twitter

Categories